BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3887750)

  • 1. Anti-A production by a group O spleen transplanted to a group A recipient.
    Salamon DJ; Ramsey G; Nusbacher J; Yang S; Starzl TE; Israel L
    Vox Sang; 1985; 48(5):309-12. PubMed ID: 3887750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe haemolysis after an ABO unmatched kidney transplant - a nonsecretor transplanted from a donor with high anti-A titre.
    Sternberg AJ; Lee G; Croxton T; Mundy N; Morris P; Littlewood TJ; Murphy MF
    Transfus Med; 2000 Mar; 10(1):87-9. PubMed ID: 10760208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation.
    Hows J; Beddow K; Gordon-Smith E; Branch DR; Spruce W; Sniecinski I; Krance RA; Petz LD
    Blood; 1986 Jan; 67(1):177-81. PubMed ID: 3079641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.
    Worel N; Greinix HT; Keil F; Mitterbauer M; Lechner K; Fischer G; Mayr W; Höcker P; Kalhs P
    Transfusion; 2002 Oct; 42(10):1293-301. PubMed ID: 12423513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against hemolysis in ABO mismatched renal transplantation.
    Mangal AK; Logan D; Sinclair M; Stillwell G
    Transfusion; 1984; 24(4):363-4. PubMed ID: 6380035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passenger lymphocyte syndrome after ABO-incompatible allogeneic hematopoietic stem cell transplantation; dynamics of ABO allo-antibody and blood type conversion.
    Teshigawara-Tanabe H; Hagihara M; Matsumura A; Takahashi H; Nakajima Y; Miyazaki T; Kamijo A; Yamazaki E; Fujimaki K; Matsumoto K; Nakajima H
    Hematology; 2021 Dec; 26(1):835-839. PubMed ID: 34672906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hemolysis caused by graft-derived anti-B production after lung transplantation.
    Taaning E; Morling N; Mortensen SA; Pettersson G; Simonsen AC
    J Heart Lung Transplant; 1996 Aug; 15(8):850-1. PubMed ID: 8878768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreas transplantation using compatible but non-identical ABO blood group donors.
    Nagaraju S; Mangus RS; Powelson JA; Fridell JA
    Clin Transplant; 2018 Jul; 32(7):e13284. PubMed ID: 29774602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-derived antibodies and hemolysis after ABO-compatible but nonidentical heart-lung and lung transplantation.
    Salerno CT; Burdine J; Perry EH; Kshettry VR; Hertz MI; Bolman RM
    Transplantation; 1998 Jan; 65(2):261-4. PubMed ID: 9458026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
    Gajewski JL; Petz LD; Calhoun L; O'Rourke S; Landaw EM; Lyddane NR; Hunt LA; Schiller GJ; Ho WG; Champlin RE
    Blood; 1992 Jun; 79(11):3076-85. PubMed ID: 1586749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolysis after whole pancreas transplantation.
    Mouquet C; Babinet J; Barrou B; Benalia H; Bitker MO; Viars P
    Transplant Proc; 1994 Apr; 26(2):430-1. PubMed ID: 8171487
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation.
    Yazer MH; Triulzi DJ
    Curr Opin Hematol; 2007 Nov; 14(6):664-70. PubMed ID: 17898572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Li JP; Zhang T; Zhong J; Chen J
    Hematology; 2007 Apr; 12(2):117-21. PubMed ID: 17454192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
    Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
    Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune hemolytic anemia after renal transplantation secondary to ABO-minor-mismatch between the donor and recipient.
    Gregoire JR
    J Am Soc Nephrol; 1993 Nov; 4(5):1122-6. PubMed ID: 8305639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated hemolytic anemia following ABO-mismatched organ transplantation: contributory role of HLA matching and polyclonal antilymphocyte globulin.
    Fabrega AJ; DeChristopher J; Sosler SD; Rivas PA; Vasquez EM; Pollak R
    Clin Transplant; 1996 Apr; 10(2):166-9. PubMed ID: 8664512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic anemia after ABO nonidentical living donor kidney transplantation.
    Bakr MA; Abbas TM; Mustafa A; Ghoneim MA
    Clin Exp Nephrol; 2009 Apr; 13(2):161-165. PubMed ID: 19153804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lethal graft-versus-host disease in a recipient of a pancreas-spleen transplant.
    Deierhoi MH; Sollinger HW; Bozdech MJ; Belzer FO
    Transplantation; 1986 Apr; 41(4):544-6. PubMed ID: 3515658
    [No Abstract]   [Full Text] [Related]  

  • 20. Alloimmune hemolysis after renal transplantation.
    Li FK; Chan TM; Lai KN
    Am J Nephrol; 2000; 20(6):473-5. PubMed ID: 11146315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.